Viatris Inc (VTRS)
18.45
-0.20 (1.07%)
Upcoming Events
Latest Headlines
Viatris (VTRS) PT Raised to $20 at JPMorgan
October 21, 2026 8:37 AM - StreetInsider
FDA approves Viatris eye drop Ryzumvi for presbyopia treatment
October 16, 2026 4:05 PM - StreetInsider
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
October 16, 2026 4:05 PM - PR NewsWire
Jefferies Downgrades Pacira Pharmaceuticals (PCRX) to Hold
October 8, 2026 12:37 PM - StreetInsider
Form 8-K Viatris Inc For: Oct 08
October 8, 2026 8:38 AM - SEC Filing
Viatris to acquire Pacira BioSciences for $1.65 billion
October 8, 2026 7:45 AM - StreetInsider
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
October 8, 2026 7:45 AM - PR NewsWire
Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026
October 5, 2026 6:59 AM - PR NewsWire
Viatris (VTRS) PT Raised to $26 at UBS
October 5, 2026 5:42 AM - StreetInsider
Form 4 Viatris Inc For: Sep 30 Filed by: Groothuis Leo Frans
October 2, 2026 6:04 PM - SEC Filing
Form 4 Viatris Inc For: Sep 30 Filed by: SIMMONS DAVID S
October 2, 2026 6:00 PM - SEC Filing
Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year
September 29, 2026 2:00 PM - PR NewsWire
Viatris sues Novo Nordisk over generic Wegovy patent dispute
September 25, 2026 3:25 PM - StreetInsider
Oppenheimer Starts Viatris (VTRS) at Outperform
September 23, 2026 6:06 AM - StreetInsider
Japan approves Viatris sleep drug Wakix for narcolepsy and sleep apnea
September 16, 2026 6:59 AM - StreetInsider
Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
September 16, 2026 6:59 AM - PR NewsWire
Viatris (VTRS) PT Raised to $13 at Piper Sandler
September 16, 2026 6:50 AM - StreetInsider
Leerink Starts Viatris (VTRS) at Outperform
September 9, 2026 6:10 AM - StreetInsider
Form 4 Viatris Inc For: Aug 15 Filed by: Enrietti Andrew
August 18, 2026 6:01 PM - SEC Filing
Form SCHEDULE 13G/A Viatris Inc Filed by: DAVIS SELECTED ADVISERS
August 12, 2026 12:00 PM - SEC Filing
Viatris Inc (VTRS) spreader of August 17 and January 15 puts
August 12, 2026 6:26 AM - StreetInsider
Form 10-Q Viatris Inc For: Jun 30
August 6, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G Viatris Inc Filed by: FMR LLC
August 6, 2026 10:44 AM - SEC Filing
Form 8-K Viatris Inc For: Aug 06
August 6, 2026 7:56 AM - SEC Filing
Viatris Inc (VTRS) Tops Q2 EPS by 8c; offers guidance
August 6, 2026 7:01 AM - StreetInsider
Viatris Reports Second-Quarter 2026 Financial Results
August 6, 2026 6:59 AM - PR NewsWire
Viatris Announces Quarterly Dividend
August 4, 2026 6:59 AM - PR NewsWire
Viatris Inc (VTRS) Declares $0.12 Quarterly Dividend; 2.7% Yield
August 4, 2026 6:59 AM - StreetInsider
FDA approves Viatris once-weekly contraceptive patch Gwyn Lo
July 29, 2026 6:59 AM - StreetInsider
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
July 29, 2026 6:59 AM - PR NewsWire
Full Article List
